ADA2 and acute myeloid leukemia: Immunohistochemical markers revealed that the tumour was negative for acute myeloid leukaemia (AML), anti-pan-cytokeratin AE1/AE3 (Cytokeratin AE1/AE3), cluster of differentiation 34 (CD34) and S100.